Balleine RL - Search Results

1

Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.

Byrne JA, Balleine RL, Schoenberg Fejzo M, Mercieca J, Chiew YE, Livnat Y, St Heaps L, Peters GB, Byth K, Karlan BY, Slamon DJ, Harnett P, Defazio A. Byrne JA, et al. Among authors: balleine rl. Int J Cancer. 2005 Dec 20;117(6):1049-54. doi: 10.1002/ijc.21250. Int J Cancer. 2005. PMID: 15986428

2

Characterization of progesterone receptor A and B expression in human breast cancer.

Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, Bilous AM, Clarke CL. Graham JD, et al. Among authors: balleine rl. Cancer Res. 1995 Nov 1;55(21):5063-8. Cancer Res. 1995. PMID: 7585552

3

Progesterone receptor A and B protein expression in human breast cancer.

Graham JD, Yeates C, Balleine RL, Harvey SS, Milliken JS, Bilous AM, Clarke CL. Graham JD, et al. Among authors: balleine rl. J Steroid Biochem Mol Biol. 1996 Jan;56(1-6 Spec No):93-8. doi: 10.1016/0960-0760(95)00226-x. J Steroid Biochem Mol Biol. 1996. PMID: 8603052 Review.

4

Expression of osteonectin mRNA in human breast tumours is inversely correlated with oestrogen receptor content.

Graham JD, Balleine RL, Milliken JS, Bilous AM, Clarke CL. Graham JD, et al. Among authors: balleine rl. Eur J Cancer. 1997 Sep;33(10):1654-60. doi: 10.1016/s0959-8049(97)00182-2. Eur J Cancer. 1997. PMID: 9389930

5

The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma.

Balleine RL, Fejzo MS, Sathasivam P, Basset P, Clarke CL, Byrne JA. Balleine RL, et al. Genes Chromosomes Cancer. 2000 Sep;29(1):48-57. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1005>3.0.co;2-o. Genes Chromosomes Cancer. 2000. PMID: 10918393

6

Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma.

Balleine RL, Earls PJ, Webster LR, Mote PA, deFazio A, Harnett PR, Clarke CL. Balleine RL, et al. Int J Gynecol Pathol. 2004 Apr;23(2):138-44. doi: 10.1097/00004347-200404000-00008. Int J Gynecol Pathol. 2004. PMID: 15084842

7

Histopathologic indicators of breast cancer biology: insights from population mammographic screening.

Webster LR, Bilous AM, Willis L, Byth K, Burgemeister FC, Salisbury EL, Clarke CL, Balleine RL. Webster LR, et al. Among authors: balleine rl. Br J Cancer. 2005 Apr 25;92(8):1366-71. doi: 10.1038/sj.bjc.6602501. Br J Cancer. 2005. PMID: 15812557 Free PMC article.

8

MRP2 (ABCC2) and cisplatin sensitivity in hepatocytes and human ovarian carcinoma.

Guminski AD, Balleine RL, Chiew YE, Webster LR, Tapner M, Farrell GC, Harnett PR, Defazio A. Guminski AD, et al. Among authors: balleine rl. Gynecol Oncol. 2006 Feb;100(2):239-46. doi: 10.1016/j.ygyno.2005.08.046. Epub 2005 Oct 5. Gynecol Oncol. 2006. PMID: 16213010

9

Histopathological features of breast cancer in carriers of ATM gene variants.

Balleine RL, Murali R, Bilous AM, Farshid G, Waring P, Provan P, Byth K, Thorne H; kConFab Investigators; Kirk JA. Balleine RL, et al. Histopathology. 2006 Nov;49(5):523-32. doi: 10.1111/j.1365-2559.2006.02538.x. Histopathology. 2006. PMID: 17064299

10

Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.

Webster LR, Lee SF, Ringland C, Morey AL, Hanby AM, Morgan G, Byth K, Mote PA, Provan PJ, Ellis IO, Green AR, Lamoury G, Ravdin P, Clarke CL, Ward RL, Balleine RL, Hawkins NJ. Webster LR, et al. Among authors: balleine rl. Clin Cancer Res. 2008 Oct 15;14(20):6625-33. doi: 10.1158/1078-0432.CCR-08-0701. Clin Cancer Res. 2008. PMID: 18927304 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters